Clinical Trial Update: SNIFF Multi-Device Study 2 [Phase 2]

View source ↗

Summary

Phase 2 multi-device clinical trial SNIFF Study 2 has completed and posted results for individuals with mild cognitive impairment and cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Mild Cognitive Impairment, Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2026-04-02